3月25日 - ** 医疗设备制造商Tenon Medical TNON.O, RIC股价盘前上涨91.2%至1.87美元
** 该公司周一表示，美国食品和药物管理局已批准 (link) TNON的Catamaran SI关节融合系统设备用于治疗骶髂(SI) 关节疾病。
** 该装置具有双重功能，既可单独治疗骶髂关节疾病，又可在脊柱融合术中提供支撑和稳定作用。
** SI 关节是骶骨（位于脊柱底部的三角形骨头）和髂骨（骨盆的一部分）之间的连接点
** 股价在过去 12 个月下跌了 87.6
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.